Today, the screeners at HealthTechMovers.com picked up 3 HealthTech Stocks up over 21% past 10 days and have been added to our watchlist. These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.
FinancialMarketPress.com is looking into these tickers DAWN, MTDR, AVY, CMC, MNST, RTX and more.
One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
Summary: Spero Therapeutics Inc. is a multi-asset, clinical-stage biopharmaceutical company. It focused on identifying, developing and commercializing novel treatments for multi-drug resistant bacterial infections. Spero Therapeutics Inc. is based in CAMBRIDGE, United States.
Recent SPRO Stock Price (approx 10:00am EST.): $2.15
Previous Close for SPRO Stock: $2.1
Percentage Price Change Past 10 Days for SPRO stock: +158%
TipRanks.com reports that Spero Therapeutics stock currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating for SPRO stock with an average price target is $6.00.
Click here to get the full story on SPRO stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Galera Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel, proprietary therapeutics to transform radiotherapy in cancer. The company's product candidate is GC4419, a highly selective and potent small molecule dismutase mimetic which is designed to rapidly convert superoxide to hydrogen peroxide. Galera Therapeutics, Inc. is headquartered in Malvern, PA.
Recent GRTX Stock Price (approx 10:00am EST.): $1.75
Previous Close for GRTX Stock: $1.75
Percentage Price Change Past 10 Days for GRTX stock: +21%
TipRanks.com reports that Galera Therapeutics stock currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating for GRTX stock with an average price target is $10.00.
Click here to get the full story on GRTX stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: IDEAYA Biosciences Inc. is an oncology-focused precision medicine company. It focuses on the discovery and development of therapeutics for patients using molecular diagnostics. The company's product pipeline consists of IDE196, MAT2A, PARG, Pol-theta and WRN which are in clinical stage. IDEAYA Biosciences Inc. is based in South San Francisco, United States.
Recent IDYA Stock Price (approx 10:00am EST.): $14.73
Previous Close for IDYA Stock: $15.25
Percentage Price Change Past 10 Days for IDYA stock: +21%
TipRanks.com reports that IDEAYA Biosciences stock currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating for IDYA stock with an average price target is $20.60.
Click here to get the full story on IDYA stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Just a reminder, one resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
The other great tool for charting is TradingView.com, so you might want to check that out too.
The information in this article was pulled from third part services. The prices listed above are not real-time and will be delayed at least 15 minutes.
FinancialMarketPress.com keeps investors informed of the top moving stocks within each sector including Health & Biotech, Technology, Energy, Metals & Mining, Financial, Consumer, Communication Services and more. We provide investors with timely information regarding top moving stocks that is sourced from our proprietary stocks screens, partner stock analysts and breaking news that identify and monitor stocks that are on the move. Join thousands of investors who already signed up for our free subscription to FinancialMarketPress.com.
